Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose Aspirin in Sickle Cell Pregnancy
NCT05253781Phase 3Completed
- Sponsor
- University of Lagos
- Start
- Jul 2020
- Primary completion
- Oct 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in intrauterine growth restriction (IUGR) and preeclampsia comparing Low Dose Aspirin with Placebo (2 arms). Primary endpoint: Number of babies with birth weight below 10th centile for gestational age, stillbirth or fetal death or miscarriages divided by the total number of babies delivered. Started Jul 2020; status: completed.
02
Drugs
aspirin
03
Conditions
intrauterine growth restriction (IUGR)preeclampsia
Beyond the preview
Go deeper on NCT05253781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05253781.